{
  "trial_id": "NCT04722692",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Preoperative diagnosis of DCIS, of any grade and any size if planned for mastectomy.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Planned Risk-reducing mastectomy, if it would be considered for upfront SLND due to institutional practice or in case of an individualised recommendation.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Any case with a preoperative diagnosis of pre-invasive or unclear lesion, that upfront SLND would be otherwise considered, such as, but not limited to: Patients with a preoperative diagnosis of DCIS grade 3 any size or, DCIS grade 2 larger than or equal to 20 mm on mammography and planned for breast conserving surgery.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a preoperative diagnosis of DCIS on core biopsy with a palpable mass on clinical examination or mass effect on radiology or",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a preoperative diagnosis of DCIS with suspicion of micro-invasion on core biopsy or",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a mammographic/ultrasound/MRI finding, suspicious for breast cancer (BIRADS 4 or 5) planned for diagnostic excision with breast conserving surgery, with no definitive diagnosis of invasive cancer or",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a preoperative diagnosis of DCIS, any grade, any size and planned for a complex oncoplastic procedure or",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a preoperative diagnosis of DCIS, any grade, any size and planned for a procedure that may compromise detection rate for a future SLND, such as, but not confined to: lesions in the upper outer quadrant or the axillary tail, removal of the nipple areola complex and so on or",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The above mentioned categories with a preoperative diagnosis of pleomorphic Lobular Cancer in Situ (pLCIS), classic Lobular Neoplasia (LN) or Atypical Ductal Hyperplasia (ADH).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The patient is a 45-year-old postmenopausal woman with cytologically confirmed breast cancer.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A core biopsy revealed a 3 cm invasive ductal breast carcinoma in the left upper outer quadrant.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The tumor is HER2-positive and ER/PR negative.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Intolerance/hypersensitivity to iron, dextran compounds or SPIO",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "An iron overload disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient deprived of liberty or under guardianship",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant or lactating patients",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "The patient is a 45-year-old postmenopausal woman with cytologically confirmed breast cancer. She has no contraindications for the trial.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT04722692",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}